Dw. Dempster et al., GLUCOCORTICOIDS INHIBIT BONE-RESORPTION BY ISOLATED RAT OSTEOCLASTS BY ENHANCING APOPTOSIS, Journal of Endocrinology, 154(3), 1997, pp. 397-406
We have studied the effects of glucocorticoids on the activity and via
bility of neonatal rat osteoclasts in vitro. In the bone slice assay,
glucocorticoids caused a dose-dependent decrease in the amount of bone
resorbed, which was accompanied by a parallel decrease in osteoclast
number. Loss of osteoclasts was due to their death, which occurred by
the process of apoptosis. Evidence for the latter was obtained by a ra
nge of techniques, including time-lapse video microscopy, acridine ora
nge staining, DNA fragment detection and transmission electron microsc
opy. Immunocytochemistry revealed the presence of glucocorticoid recep
tors in osteoclasts, and glucocorticoid-induced cell death could be pr
evented by the glucocorticoid receptor antagonist, RU486. These observ
ations suggest that glucocorticoids promote receptor-mediated apoptosi
s of rat osteoclasts in vitro. This finding may help to explain recent
data indicating that, in sharp contrast with their effects on the hum
an skeleton, glucocorticoids inhibit bone resorption and increase bone
mass in rats in vivo.